Abstract Chimeric Antigen Receptor T-cell (CAR-T) therapies are having remarkable success in treating certain cancers, but global accessibility to treatments like these is limited. This
Abstract This whitepaper explores both the challenges and opportunities associated with workforce development within the context of the Decentralized Manufacturing Model (DMM) for producing Advanced
Abstract Advanced Therapeutic Medicinal Products (ATMPs), particularly Cell and Gene Therapies (CGTs), are pivotal in regenerative medicine. However, there’s a significant shortage in manufacturing capacity
Abstract Over the past decade, Advanced Therapeutic Medicinal Products (ATMPs), including Cell and Gene Therapies (CGTs), have revolutionized treatment options, particularly for patients with blood cancers. Despite
Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Vivamus suscipit tortor eget felis porttitor volutpat. Quisque velit nisi, pretium ut lacinia in, elementum id enim. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Cras ultricies ligula sed magna dictum porta.
